PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency Medicine, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.\', \'Department of Emergency Medicine, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark; Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.\', \'Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.\', \'Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark; Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.\', \'Department of Emergency Medicine, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark; Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark; Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0736-4679(21)00295-X10.1016/j.jemermed.2021.03.012
?:doi
?:hasPublicationType
?:journal
  • The Journal of emergency medicine
is ?:pmid of
?:pmid
?:pmid
  • 34092446
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all